![Hui Ping Wu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hui Ping Wu
Directeur/Bestuurslid bij XinYu Pharmaceutical Co., Ltd.
Profiel
Hui Ping Wu is an Independent Director at XinYu Pharmaceutical Co., Ltd.
since 2016.
Prior to this, Wu was an Independent Director at Shanghai Tongda Venture Capital Co., Ltd.
Actieve functies van Hui Ping Wu
Bedrijven | Functie | Begin |
---|---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Directeur/Bestuurslid | 01-12-2016 |
Eerdere bekende functies van Hui Ping Wu
Bedrijven | Functie | Einde |
---|---|---|
SHANGHAI TONGDA VENTURE CAPITAL CO., LTD. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SHANGHAI TONGDA VENTURE CAPITAL CO., LTD. | Finance |
Bedrijven in privébezit | 1 |
---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |